Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Ekso Bionics Holdings, Inc. EKSO
$1.58
-$0.02 (-1.25%)
На 18:01, 12 мая 2023
+469.62%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
21697810.00000000
-
week52high
2.95
-
week52low
1.03
-
Revenue
12912000
-
P/E TTM
-2
-
Beta
1.80761200
-
EPS
-1.13000000
-
Last Dividend
0.00000000
-
Next Earnings Date
26 июл 2023 г. в 10:59
Описание компании
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 29 июл 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 25 ноя 2020 г. |
| Aegis Capital | Buy | Buy | 25 ноя 2020 г. |
| HC Wainwright & Co. | Buy | Buy | 30 окт 2020 г. |
| Aegis Capital | Buy | Buy | 03 авг 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| SHERMAN STEVEN | D | 0 | 31198 | 04 дек 2022 г. |
| SHERMAN STEVEN | A | 971343 | 242679 | 04 дек 2022 г. |
| SHERMAN STEVEN | D | 728664 | 10576 | 04 дек 2022 г. |
| SHERMAN STEVEN | A | 739240 | 31198 | 04 дек 2022 г. |
| Jones Jason C | A | 141989 | 17007 | 04 дек 2022 г. |
| Stern Stanley | A | 167008 | 87787 | 04 дек 2022 г. |
| SHERMAN STEVEN | D | 31199 | 15599 | 21 ноя 2022 г. |
| SHERMAN STEVEN | D | 708042 | 5787 | 21 ноя 2022 г. |
| SHERMAN STEVEN | A | 713829 | 15599 | 21 ноя 2022 г. |
| Jones Jason C | D | 124982 | 782 | 16 ноя 2022 г. |
Новостная лента
Ekso Bionics Holdings, Inc. (EKSO) Q1 2023 Earnings Call Transcript
Seeking Alpha
27 апр 2023 г. в 22:09
Ekso Bionics Holdings, Inc. (EKSO) Q1 2023 Earnings Call Transcript.
Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023
GlobeNewsWire
20 апр 2023 г. в 08:00
SAN RAFAEL, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the first quarter 2023 after the close of trading on Thursday, April 27, 2023. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.
Ekso Bionics Holdings, Inc. (EKSO) Q4 2022 Earnings Call Transcript
Seeking Alpha
28 мар 2023 г. в 18:08
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q4 2022 Earnings Conference Call March 28, 2023 4:30 PM ET Company Participants Matt Steinberg - Investor Relations, FINN Partners Scott Davis - Chief Executive Officer Jason Jones - Chief Operating Officer Jerome Wong - Chief Financial Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Operator Greetings, and welcome to the Ekso Bionics Fourth Quarter 2022 Financial Results Conference Call.
Ekso Bionics Holdings, Inc. (EKSO) Q3 2022 Earnings Call Transcript
Seeking Alpha
06 ноя 2022 г. в 11:25
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Matt Steinberg - Investor Relations Steven Sherman - Chairman and Chief Executive Officer Scott Davis - President and Chief Operating Officer Jerome Wong - Chief Financial Officer Operator Greetings and welcome to Ekso Bionics Third Quarter 2022 Financial Results Call. [Operator Instructions] As a reminder, this conference is being recorded.
Ekso Bionics (EKSO) Reports Q3 Loss, Lags Revenue Estimates
Zacks Investment Research
03 ноя 2022 г. в 19:35
Ekso Bionics (EKSO) delivered earnings and revenue surprises of -37.50% and 7.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?